Wednesday, November 20, 2019
With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests – TechCrunch
A little over a year after the dissolution of the once high-flying blood testing startup Theranos, another startup has raised more than $27 million to breathe new life into the vision of bringing low-cost blood tests to point-of-care medical facilities. Unlike Theranos, Truvian Sciences is not claiming that most of its blood tests do not need clearance from the U.S. Food and Drug Administration,
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Threat actors are exploiting ProxyLogon and ProxyShell exploits in unpatched Microsoft Exchange Servers as part of an ongoing spam campaign
-
You might not need to panic. BroadSoft tells Gizmodo that it locked down its Amazon data (Charter says it was taken down) and hasn’t seen ev...
-
The connection between the Apple Watch and an iPhone is the core of Apple’s wearable experience, and for the first time, the company gave th...
No comments:
Post a Comment